Views 520
Citations 0
News From the Food and Drug Administration
September 15, 2015

Adverse Events Linked With LVADs

Author Affiliations

Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2015;314(11):1108. doi:10.1001/jama.2015.11142

The 2 FDA-approved implantable left ventricular assist devices (LVADs) currently on the market have been linked with serious adverse events, including stroke and bleeding complications (

Implantable LVADs, which circulate blood throughout the body in patients with advanced heart failure, consist of a blood pump, power pack, and controller. The pump is attached to the heart’s left ventricle and the aorta, while the power pack and controller are connected to the pump but remain outside the body.

First Page Preview View Large
First page PDF preview
First page PDF preview